Rapid Quantitation of Alcohol Metabolite Markers in Urine

Ethyl glucuronide (EtG) and ethyl sulfate (EtS) are direct metabolites of ethanol. Despite the fact that just a small portion of the ethanol consumed by humans is transformed into this pair of compounds, they are employed as biomarkers for consumption or abstinence from alcohol, for example, in tests determining fitness to drive.

Figure 1. EVOQ triple quadrupole MS with Elute UHPLC

It is still possible to detect these compounds in urine, even once ethanol concentration can no longer be measured, since their window of detection in this form is around 3-5 days. The typical cut-off value for EtG is approximately 100 ng/mL.

With EtG, there is a risk of both false-negative results, which can happen as a result of bacterial degradation, for example, with a urinary tract infection, and false-positive results, which can happen following the use of ethanol-based mouthwash or hand-sanitizers.

This is why the inclusion of EtS in the assay is vital. A specific detection process capable of picking up both EtG and EtS can be achieved through High Performance Liquid chromatography (HPLC) along with a triple quadrupole mass spectrometer.

Experimental

Samples

Recipe (Munich) provided urine calibrators at six diverse concentrations (Table 2), as well as a quality control sample. Analysis was carried out on two samples of a round robin test arranged by the “Society of Toxicological and Forensic Chemistry” (GTFCh).

Additionally, urine samples of two people (both social drinkers; individual 1 female, 30 y, 61 kg; individual 2 male, 37 y, 64 kg) were gathered 3 and 24 hours after each had ingested one glass of wine (200 mL) and one glass of spirits (20 mL).

Sample Preparation

Urine samples were placed in a centrifuge at 4000 rpm for 10 min. 100 µL urine, 20 µL internal standard solutions (5 µg/ mL EtG-d5 and EtS-d5) and 250 µL methanol were added to an Eppendorf tube.

Following vortexing, the tubes were placed in the centrifuge and 270 µL supernatant were transmitted into an HPLC vial. Evaporation of the supernatant took place in a vacuum concentrator at 45 °C and the residue re-formed in 600 µL 0.1% formic acid.

Figure 2. Calibration curves of EtG (left) and EtS (right) over the range 80 - 9621 ng/mL (EtG) and 27 - 4732 ng/mL (EtS)

Results and Discussion

Calibration curves demonstrated exceptional linearity (r² ≥ 0.999) and a high standard of accuracy with bias < ±8% for both EtG and EtS (Figure 2, Table 2). Strong accuracy was also found in the quality control sample, with a deviation of 9.4% for both analytes.

Replicate injections (n=5) of the two round robin test samples revealed outstanding accuracy, with RSD ≤ 2.8% for each compound. The quantitative results all fell inside the accepted range (Table 3).

EtG and EtS were each distinguished in the two genuine samples. The concentrations actually surpassed the calibration range in the samples collected 3 hours after the ingestion of alcoholic drinks. 24 hours after the ingestion, both analytes could still be detected in the two samples (Table 4).

The innovative Elute UHPLC system delivered outstanding chromatographic peak shape and a FWHM (full width half maximum) of just 3-4 seconds, as presented in Fig. 3.

Figure 3. Overlaid chromatograms of the five replicates of round robin test sample 1; left peak EtS, right peak EtG

Table 1. MRM transitions

Table 2. Calibration and QC of EtG and EtS

Table 3. Results of round robin test

Table 4. Results of real samples; * concentration above calibration range

Conclusion

A rapid, 3 minute method to detect and quantify EtG and EtS in urine with the new Bruker Elute UHPLC coupled to the EVOQ Elite triple quadrupole MS was demonstrated. The technique offers outstanding linearity and excellent accuracy. Both EtG and EtS were distinguished in the two genuine samples.

About Bruker Life Sciences Mass Spectrometry

Discover new ways to apply mass spectrometry to today’s most pressing analytical challenges. Innovations such as Trapped Ion Mobility (TIMS), smartbeam and scanning lasers for MALDI-MS Imaging that deliver true pixel fidelity, and eXtreme Resolution FTMS (XR) technology capable to reveal Isotopic Fine Structure (IFS) signatures are pushing scientific exploration to new heights. Bruker's mass spectrometry solutions enable scientists to make breakthrough discoveries and gain deeper insights.

Sponsored Content Policy: News-Medical.net publishes articles and related content that may be derived from sources where we have existing commercial relationships, provided such content adds value to the core editorial ethos of News-Medical.Net which is to educate and inform site visitors interested in medical research, science, medical devices and treatments.